Pfizer (PFE) Chief Executive Albert Bourla said the company's dispute with activist investor Starboard Value is over issues "on the margins" of its business and is not "an aggressive situation," Bloomberg reported Tuesday, citing lunchtime remarks with a group of reporters.
Bourla said Starboard has not demanded major changes such as cost cuts, board reshuffles, or a corporate breakup, the report cited Bourla as saying.
"I respect Starboard, and I try to be engaged with them," Bourla reportedly said. "If they have good ideas, we will do it."
Starboard did not immediately reply to MT Newswires' request for comment.
(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.